Evidence method
Level · gp.fundamentals.debt_to_revenue
46.08% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ATRC · Sep 30, 2025
AtriCure, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001323885-25-000103General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
1.94% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
19.90% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
15.84% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
58.80% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
75.47% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
0.15% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
17.05% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
9.25% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History55 statesSelf-history eligible
Sep 30, 20219/9 normalizedLevel 3Dec 31, 20219/9 normalizedLevel 3Mar 31, 20229/9 normalizedLevel 3Jun 30, 20229/9 normalizedLevel 3Sep 30, 20229/9 normalizedLevel 3Dec 31, 20229/9 normalizedLevel 3Mar 31, 20239/9 normalizedLevel 3Jun 30, 20239/9 normalizedLevel 3Sep 30, 20239/9 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20249/9 normalizedLevel 3Jun 30, 20249/9 normalizedLevel 3Sep 30, 20249/9 normalizedLevel 3Dec 31, 20249/9 normalizedLevel 3Mar 31, 20259/9 normalizedLevel 3Jun 30, 20259/9 normalizedLevel 3Sep 30, 20259/9 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20269/9 normalizedLevel 3Jun 30, 20269/9 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 45.44%
- Current
- 46.08%
- Delta
- 0.63%
- Previous
- 1.96%
- Current
- 1.94%
- Delta
- -0.02%
- Previous
- 15.88%
- Current
- 19.90%
- Delta
- 4.02%
- Previous
- 17.09%
- Current
- 15.84%
- Delta
- -1.25%
- Previous
- 56.08%
- Current
- 58.80%
- Delta
- 2.72%
- Previous
- 74.54%
- Current
- 75.47%
- Delta
- 0.93%
- Previous
- -4.55%
- Current
- 0.15%
- Delta
- 4.70%
- Previous
- 21.51%
- Current
- 17.05%
- Delta
- -4.46%
- Previous
- 8.35%
- Current
- 9.25%
- Delta
- 0.90%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · ATRC Fundamental State →Analogous To · ATRC state analogue 4 →Has State · AtriCure, Inc. →Transitioned To · ATRC Fundamental State →Transitioned To · ATRC BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · ATRC CAPEX_INTENSITY_DECREASED →Transitioned To · ATRC CASH_GENERATION_INCREASED →Transitioned To · ATRC GROWTH_DECREASED →Transitioned To · ATRC INVENTORY_PRESSURE_INCREASED →Transitioned To · ATRC MARGIN_INCREASED →Transitioned To · ATRC PROFITABILITY_INCREASED →Transitioned To · ATRC R_AND_D_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.